Details of the Drug
General Information of Drug (ID: DMLKN9P)
| Drug Name |
Anti-tubulin agents
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
JAC program, Jeil; JAC-106; JI-1106; JL-1106; Anti-tubulin agents (multidrug-resistant cancer); Antitubulin agents (MDR cancer), Jeil/Korea Research Institute of Bioscience and Biotechnology; Anti-tubulin agents (multidrug-resistant cancer), Jeil/KRIBB
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||